Valeo Financial Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-27,473
| Closed | -$9.89K | – | 663 |
|
|
2023
Q1 | $9.89K | Hold |
27,473
| – | – | ﹤0.01% | 610 |
|
|
2022
Q4 | $24.3K | Buy |
27,473
+1,000
| +4% | +$886 | ﹤0.01% | 527 |
|
|
2022
Q3 | $42K | Buy |
26,473
+7,000
| +36% | +$11.1K | ﹤0.01% | 468 |
|
|
2022
Q2 | $39K | Hold |
19,473
| – | – | ﹤0.01% | 464 |
|
|
2022
Q1 | $45K | Buy |
19,473
+5,000
| +35% | +$11.6K | ﹤0.01% | 564 |
|
|
2021
Q4 | $67K | Buy |
14,473
+100
| +0.7% | +$463 | ﹤0.01% | 526 |
|
|
2021
Q3 | $110K | Buy |
14,373
+1,373
| +11% | +$10.5K | 0.01% | 499 |
|
|
2021
Q2 | $126K | Hold |
13,000
| – | – | 0.01% | 429 |
|
|
2021
Q1 | $108K | Buy |
13,000
+3,000
| +30% | +$24.9K | 0.01% | 573 |
|
|
2020
Q4 | $68K | Hold |
10,000
| – | – | ﹤0.01% | 666 |
|
|
2020
Q3 | $112K | Buy |
10,000
+6,000
| +150% | +$67.2K | 0.01% | 444 |
|
|
2020
Q2 | $25K | Buy |
+4,000
| New | +$25K | ﹤0.01% | 933 |
|